Litcius/Paper detail

Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study

Tomoko Ueda‐Consolvo, Aya Tanigichi, Ayaka Numata, Toshihiko Oiwake, Tomoko Nakamura, Masaaki Ishida, Shuichiro Yanagisawa, Atsushi Hayashi

2022Graefe s Archive for Clinical and Experimental Ophthalmology23 citationsDOI

Topics & Concepts

AfliberceptMedicineChoroidal neovascularizationLesionMacular degenerationOphthalmologyVisual acuityConfidence intervalSurgeryInternal medicineBevacizumabChemotherapyRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Development and Disorders
Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study | Litcius